Giuseppe Ciliberti, Monica Verdoia, Marco Merlo, Filippo Zilio, Marco Vatrano, Francesco Bianco, Massimo Mancone, Denise Zaffalon, Alessia Bonci, Andrea Boscutti, Fabio Infusino, Stefano Coiro, Giulia Stronati, Isabella Tritto, Rocco Gioscia, Antonio Dello Russo, Francesco Fedele, Sabina Gallina, Francesco Cassadonte, Giuseppe Ambrosio, Roberto Bonmassari, Giuseppe De Luca, Gianfranco Sinagra, Alessandro Capucci, Juan Carlos Kaski, Federico Guerra
AIMS: To assess the effect of pharmacological therapy on long-term prognosis of patients with MINOCA. METHODS AND RESULTS: In this retrospective multicentre cohort study involving 9 Hub Hospitals across Italy we enrolled consecutive patients 18 years and older with diagnosis of MINOCA discharged from 1st March 2012 to 31st March 2018. Data on baseline characteristics and pharmacological therapy at discharge (ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor antagonists; ASA, acetylsalicylic acid; beta-blockers; CCB, calcium-channel blockers; DAPT, dual anti-platelet therapy; statins), were collected systematically...
March 15, 2021: International Journal of Cardiology